Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies

4 Feb 2011

Abstract excerpt

OBJECTIVE: To investigate whether congenital IGF1 deficiency confers protection against development of malignancies, by comparing the prevalence of malignancies in patients with congenital (secondary) deficiency of IGF1 with the prevalence of cancer in their family members. METHOD: Only patients with an ascertained diagnosis of either Laron syndrome (LS), congenital IGHD, congenital multiple pituitary hormone...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Growth Hormone and Insulin-like Growth Factors
Share to Pituitary Gland Disorders and Treatments
Share to Thyroid Disorders and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21292919
DOI: 10.1530/eje-10-0859

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Congenital IGF1 deficiency tends to confer protection against post-natal development of malignanciesPMID 21292919Read ↗

Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: A preliminary reportSemantic proximity Read ↗

Congenital IGF-1 deficiency protects from cancer: lessons from Laron syndromeSemantic proximity Read ↗

Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection PathwaysSemantic proximity Read ↗

Identification of signaling pathways associated with cancer protection in Laron syndromeSemantic proximity Read ↗

IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome.Semantic proximity Read ↗

Clinical and Molecular Features of Laron Syndrome, A Genetic Disorder Protecting from Cancer.Semantic proximity Read ↗

Growth hormone and cancerSemantic proximity Read ↗

Laron Syndrome Research Paves the Way for New Insights in Oncological InvestigationSemantic proximity Read ↗

Insulin-like growth factors and aging: lessons from Laron syndromeSemantic proximity Read ↗

Involvement of the IGF system in fetal growth and childhood cancer: an overview of potential mechanismsSemantic proximity Read ↗

Occurrence of neoplasms in individuals with congenital, severe GH deficiency from the Itabaianinha kindred.Semantic proximity Read ↗

Insulin-like growth factor 1 (IGF-1): a growth hormoneSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.